OncoCyte Investor Relations Material
Latest events
Q1 2025
OncoCyte
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from OncoCyte Corporation
Access all reports
OncoCyte Corporation develops and markets molecular diagnostics for use in oncology and transplantation. The company focuses on liquid biopsy technologies and gene expression testing to support clinical decision-making in patient care. Its services are aimed at healthcare providers and research institutions. The company is headquartered in Irvine, California, and its shares are listed on the NASDAQ.
Key slides for OncoCyte Corporation
Investor Presentation
OncoCyte Corporation
Investor Presentation
OncoCyte Corporation
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
OCX
Country
🇺🇸 United States